Photodynamic therapy of cancer: An update
暂无分享,去创建一个
David Kessel | Kristian Berg | Patrizia Agostinis | Mladen Korbelik | Johan Moan | Michael R Hamblin | Pawel Mroz | Asta Juzeniene | Dominika Nowis | Jakub Golab | B. Wilson | S. Hahn | K. Berg | J. Moan | T. Foster | P. Agostinis | K. Cengel | A. Girotti | S. Gollnick | M. Hamblin | A. Juzeniene | D. Kessel | M. Korbelik | P. Mróz | D. Nowis | J. Piette | J. Gołąb | Michael R. Hamblin | Brian C. Wilson | Keith A. Cengel | Thomas H. Foster | Albert W. Girotti | Sandra O. Gollnick | Stephen M. Hahn | Jacques Piette
[1] T. Hampton. Targeted cancer therapies lagging: better trial design could boost success rate. , 2006, JAMA.
[2] Michael T. Tseng,et al. PHOTODYNAMIC THERAPY INDUCED ULTRASTRUCTURAL ALTERATIONS IN MICROVASCULATURE OF THE RAT CREMASTER MUSCLE , 1988, Photochemistry and photobiology.
[3] G. Singh,et al. Induction of Hsp60 by Photofrin-mediated photodynamic therapy. , 2001, Journal of photochemistry and photobiology. B, Biology.
[4] H. Kato,et al. Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer. , 1982, Chest.
[5] Barbara W Henderson,et al. Generation of effective antitumor vaccines using photodynamic therapy. , 2002, Cancer research.
[6] Claudio H. Sibata,et al. Oncologic photodynamic therapy photosensitizers: a clinical review. , 2010, Photodiagnosis and photodynamic therapy.
[7] W. Mueller‐Klieser,et al. The anti-oxidant capacity of tumour glycolysis , 2009, International journal of radiation biology.
[8] Timothy Zhu,et al. Phase II Trial of Debulking Surgery and Photodynamic Therapy for Disseminated Intraperitoneal Tumors , 2001, Annals of Surgical Oncology.
[9] Tayyaba Hasan,et al. Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity. , 2003, Cancer research.
[10] Menno A de Rie,et al. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. , 2007, Archives of dermatology.
[11] T. Dougherty,et al. Endobronchial photodynamic therapy for lung cancer , 2006, Lasers in surgery and medicine.
[12] Barbara W. Henderson,et al. Choice of Oxygen-Conserving Treatment Regimen Determines the Inflammatory Response and Outcome of Photodynamic Therapy of Tumors , 2004, Cancer Research.
[13] M Emberton,et al. Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer , 2006, Lasers in surgery and medicine.
[14] H. Kostron,et al. Photodynamic therapy of malignant brain tumours: a phase I/II trial. , 1988, British journal of neurosurgery.
[15] C J Gomer,et al. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. , 2000, Cancer research.
[16] M. Korbelik,et al. Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy. , 1995, British Journal of Cancer.
[17] W. Star,et al. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. , 1986, Cancer research.
[18] Wiley Interscience,et al. Protoporphyrin IX fluorescence photobleaching is a useful tool to predict the response of rat ovarian cancer following hexaminolevulinate photodynamic therapy , 2008, Lasers in surgery and medicine.
[19] Bergein F Overholt,et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. , 2005, Gastrointestinal endoscopy.
[20] D. Kessel,et al. Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves bid cleavage , 2002, Cell Death and Differentiation.
[21] H. Schild,et al. Heat shock proteins as ligands of toll-like receptors. , 2002, Current topics in microbiology and immunology.
[22] S. Steinberg,et al. Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma , 1997, Annals of Surgical Oncology.
[23] Rik Roelandts,et al. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. , 2008, European journal of dermatology : EJD.
[24] H. Wolfsen. Carpe luz--seize the light: endoprevention of esophageal adenocarcinoma when using photodynamic therapy with porfimer sodium. , 2005, Gastrointestinal endoscopy.
[25] R. K. Davis. Photodynamic therapy in otolaryngology-head and neck surgery. , 1990, Otolaryngologic clinics of North America.
[26] Michael R Hamblin,et al. Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response. , 2009, Cancer research.
[27] A. Giatromanolaki,et al. Outcome of patients receiving photodynamic therapy for early esophageal cancer. , 2000, International journal of radiation oncology, biology, physics.
[28] R. D. Barabash,et al. Photodynamic therapy to treat tumors of the extrahepatic biliary ducts. A case report. , 1991, Archives of surgery.
[29] C. Gomer,et al. The effect of localized porphyrin photodynamic therapy on the induction of tumour metastasis. , 1987, British Journal of Cancer.
[30] W. Jerjes,et al. The surgical palliation of advanced head and neck cancer using photodynamic therapy. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).
[31] R. Supino,et al. On the combination of photodynamic therapy with ionizing radiation. , 1999, Journal of photochemistry and photobiology. B, Biology.
[32] R. M. Szeimiesa,et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. , 2002 .
[33] B W Henderson,et al. OXYGEN LIMITATION OF DIRECT TUMOR CELL KILL DURING PHOTODYNAMIC TREATMENT OF A MURINE TUMOR MODEL , 1989, Photochemistry and photobiology.
[34] P. Seed,et al. A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. , 1999, Journal of the American Academy of Dermatology.
[35] D. Piacquadio,et al. Short incubation PDT versus 5-FU in treating actinic keratoses. , 2003, Journal of drugs in dermatology : JDD.
[36] P. McCarron,et al. Photosensitiser delivery for photodynamic therapy. Part 2: systemic carrier platforms. , 2008, Expert opinion on drug delivery.
[37] K. Berg,et al. Assessing autophagy in the context of photodynamic therapy , 2010, Autophagy.
[38] J. Karbach,et al. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[39] J E Kaufman,et al. Photoradiation therapy for the treatment of malignant tumors. , 1978, Cancer research.
[40] J. Kennedy,et al. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.
[41] M. Berns,et al. Combination cytotoxic chemotherapy with cisplatin or doxorubicin and photodynamic therapy in murine tumors. , 1988, Journal of the National Cancer Institute.
[42] M. Mason,et al. A phase‐1 study of sequential mitomycin C and 5–aminolaevulinic acid‐mediated photodynamic therapy in recurrent superficial bladder carcinoma , 2005, BJU international.
[43] C. Hadjur,et al. Photodynamic Effects of Hypericin on Lipid Peroxidation and Antioxidant Status in Melanoma Cells , 1996, Photochemistry and photobiology.
[44] D. Traul,et al. POTENTIATION OF MEROCYANINE 540‐MEDIATED PHOTODYNAMIC THERAPY BY SALICYLATE and RELATED DRUGS , 1995, Photochemistry and photobiology.
[45] F. Berr,et al. Photophysics and photochemistry of photodynamic therapy: fundamental aspects , 2009, Lasers in Medical Science.
[46] D. Murrell,et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix®) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study , 2003, The Journal of dermatological treatment.
[47] D. V. Ash,et al. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. , 1994, British Journal of Cancer.
[48] P. Speight,et al. Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid , 1993, The Lancet.
[49] K. Soo,et al. The effect of photodynamic therapy on tumor angiogenesis , 2009, Cellular and Molecular Life Sciences.
[50] S. Wang,et al. Talaporfin sodium , 2010, Expert opinion on pharmacotherapy.
[51] C. Sibata,et al. Results of combined photodynamic therapy (PDT) and high dose rate brachytherapy (HDR) in treatment of obstructive endobronchial non-small cell lung cancer (NSCLC). , 2010, Photodiagnosis and photodynamic therapy.
[52] J. McCaughan,et al. Photodynamic therapy for endobronchial malignant disease: a prospective fourteen-year study. , 1997, The Journal of thoracic and cardiovascular surgery.
[53] Jitsuo Usuda,et al. Domain-dependent Photodamage to Bcl-2 , 2003, The Journal of Biological Chemistry.
[54] M. Chopp,et al. Combination Therapy with Antiangiogenic Treatment and Photodynamic Therapy for the Nude Mouse Bearing U87 Glioblastoma , 2007, Photochemistry and photobiology.
[55] Paola Taroni,et al. Immunopharmacology studies on photosensitizers used in photodynamic therapy , 1994, Other Conferences.
[56] Petras Juzenas,et al. Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy , 2004, Lasers in Medical Science.
[57] J. Feyh,et al. Photodynamic therapy in head and neck surgery. , 1990, Journal of photochemistry and photobiology. B, Biology.
[58] Tetsuya Nakamura,et al. Photodynamic therapy with polypectomy for rectal cancer. , 2003, Gastrointestinal endoscopy.
[59] Britton Chance,et al. Protease-triggered photosensitizing beacon based on singlet oxygen quenching and activation. , 2004, Journal of the American Chemical Society.
[60] R. Babayan,et al. Carcinoma in situ of the bladder , 1983, World Journal of Urology.
[61] Nancy L Oleinick,et al. The role of apoptosis in response to photodynamic therapy: what, where, why, and how , 2002, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[62] D. Kessel,et al. Potentiation of photodynamic therapy by ursodeoxycholic acid. , 2000, Cancer research.
[63] B. Wilson,et al. Photodynamic molecular beacon as an activatable photosensitizer based on protease-controlled singlet oxygen quenching and activation , 2007, Proceedings of the National Academy of Sciences.
[64] M. Corbett,et al. A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin. , 2010, Health technology assessment.
[65] M. Korbelik,et al. Activation of complement C3, C5, and C9 genes in tumors treated by photodynamic therapy , 2007, Cancer Immunology, Immunotherapy.
[66] J Moan,et al. Enhanced antitumour effect of photodynamic therapy by microtubule inhibitors. , 1996, Cancer letters.
[67] R. Weersink,et al. Photodynamic therapy for urological malignancies: past to current approaches. , 2006, The Journal of urology.
[68] Michael R Hamblin,et al. On the mechanism of the tumour-localising effect in photodynamic therapy. , 1994, Journal of photochemistry and photobiology. B, Biology.
[69] A. Rainbow,et al. Up‐regulation of Hsp27 Plays a Role in the Resistance of Human Colon Carcinoma HT29 Cells to Photooxidative Stress ¶ , 2002, Photochemistry and photobiology.
[70] B. Overholt,et al. What is the best management strategy for high grade dysplasia in Barrett’s oesophagus? A cost effectiveness analysis , 2003, Gut.
[71] Chung-Ho Sun,et al. Immunophototherapy Using PDT Combined with Rapid Intratumoral Dendritic Cell Injection , 2008, Photochemistry and photobiology.
[72] M. Wallace,et al. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer , 2004, Alimentary pharmacology & therapeutics.
[73] B. Wilson,et al. "Zipper" molecular beacons: a generalized strategy to optimize the performance of activatable protease probes. , 2009, Bioconjugate chemistry.
[74] L. Dubertret,et al. LOVASTATIN POTENTIATES THE PHOTOCYTOTOXIC EFFECT OF PHOTOFRIN II DELIVERED TO HT29 HUMAN COLONIC ADENOCARCINOMA CELLS BY LOW DENSITY LIPOPROTEIN , 1993, Photochemistry and photobiology.
[75] M. Biel. Advances in photodynamic therapy for the treatment of head and neck cancers , 2006, Lasers in surgery and medicine.
[76] Tetsuya Watanabe,et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death , 2005, Nature.
[77] Patrizia Agostinis,et al. Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. , 2007, Biochimica et biophysica acta.
[78] K. Koshida,et al. Whole bladder wall photodynamic therapy for refractory carcinoma in situ of the bladder. , 1995, British Journal of Cancer.
[79] P. Mróz,et al. Erythropoietin restores the antitumor effectiveness of photodynamic therapy in mice with chemotherapy-induced anemia. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[80] T. Hasan,et al. Benzophenothiazine and Benzoporphyrin Derivative Combination Phototherapy Effectively Eradicates Large Murine Sarcomas , 1996, Photochemistry and photobiology.
[81] E. Farrero,et al. Efficacy and safety of photodynamic therapy versus Nd-YAG laser resection in NSCLC with airway obstruction. , 1999, The European respiratory journal.
[82] A. Oseroff,et al. Enhanced Systemic Immune Reactivity to a Basal Cell Carcinoma Associated Antigen Following Photodynamic Therapy , 2009, Clinical Cancer Research.
[83] Stephen G Bown,et al. Photodynamic therapy of malignant biliary strictures using meso-tetrahydroxyphenylchlorin , 2007, European journal of gastroenterology & hepatology.
[84] A. Hauschild,et al. Long‐term follow‐up of photodynamic therapy with a self‐adhesive 5‐aminolaevulinic acid patch: 12 months data , 2010, The British journal of dermatology.
[85] Robert A Weersink,et al. Assessment of Cutaneous Photosensitivity of TOOKAD (WST09) in Preclinical Animal Models and in Patients¶ , 2005, Photochemistry and photobiology.
[86] P. Mróz,et al. Inhibition of cyclooxygenase-2 indirectly potentiates antitumor effects of photodynamic therapy in mice. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[87] M. Olivo,et al. Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models , 2005, Cancer Chemotherapy and Pharmacology.
[88] W. Ahn,et al. Photodynamic therapy with recombinant adenovirus AdmIL‐12 enhances anti‐tumour therapy efficacy in human papillomavirus 16 (E6/E7) infected tumour model , 2008, Immunology.
[89] Herwig Kostron,et al. Photodynamic diagnosis and therapy and the brain. , 2010, Methods in molecular biology.
[90] C. Gomer,et al. Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response. , 2002, Cancer research.
[91] U. Nseyo,et al. Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional-cell carcinoma of the bladder. , 1987, The New England journal of medicine.
[92] A. Taub. Photodynamic therapy: other uses. , 2007, Dermatologic clinics.
[93] A H Kaye,et al. Adjuvant high-dose photoradiation therapy in the treatment of cerebral glioma: a phase 1-2 study. , 1987, Journal of neurosurgery.
[94] Mladen Korbelik,et al. PDT‐associated host response and its role in the therapy outcome , 2006, Lasers in surgery and medicine.
[95] B. Wilson. PHOTONIC AND NON-PHOTONIC BASED NANOPARTICLES IN CANCER IMAGING AND THERAPEUTICS , 2006 .
[96] Aleksander Rebane,et al. Blood-vessel closure using photosensitizers engineered for two-photon excitation , 2008 .
[97] Qian Peng,et al. Photodynamic therapy targets the mTOR signaling network in vitro and in vivo. , 2009, Molecular pharmaceutics.
[98] C. Swain,et al. Photodynamic therapy for malignant tumours of the ampulla of Vater. , 1995, Gut.
[99] J. Carruthers,et al. The use of photodynamic therapy in dermatology: results of a consensus conference. , 2006, Journal of drugs in dermatology : JDD.
[100] M. Korbelik,et al. Exploitation of Immune Response‐eliciting Properties of Hypocrellin Photosensitizer SL052‐based Photodynamic Therapy for Eradication of Malignant Tumors , 2009, Photochemistry and photobiology.
[101] Christopher S. Foote,et al. Mechanisms of Photosensitized Oxidation , 1968 .
[102] H Stepp,et al. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. , 2000, Journal of neurosurgery.
[103] B. Wilson,et al. Interstitial in vivo ALA-PpIX mediated metronomic photodynamic therapy (mPDT) using the CNS-1 astrocytoma with bioluminescence monitoring. , 2007, Photodiagnosis and photodynamic therapy.
[104] D. Kessel,et al. Evidence that bcl-2 is the Target of Three Photosensitizers that Induce a Rapid Apoptotic Response¶ , 2001, Photochemistry and photobiology.
[105] D. Apel,et al. Palliation of Nonresectable Bile Duct Cancer: Improved Survival After Photodynamic Therapy , 2005, The American Journal of Gastroenterology.
[106] C. Gomer,et al. The Matrix Metalloproteinase Inhibitor Prinomastat Enhances Photodynamic Therapy Responsiveness in a Mouse Tumor Model , 2004, Cancer Research.
[107] Tayyaba Hasan,et al. Nanotechnology-based combination therapy improves treatment response in cancer models , 2009, World Congress of the International Photodynamic Association.
[108] B. Wilson,et al. Photodynamic therapy for recurrent supratentorial gliomas. , 1995, Seminars in surgical oncology.
[109] F. Zanella,et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.
[110] Tuan Vo-Dinh,et al. Biomedical Photonics Handbook , 2003 .
[111] S. Krishnamurthy,et al. Optimal light dose for interstitial photodynamic therapy in treatment for malignant brain tumors. , 2000, Lasers in surgery and medicine.
[112] Keith A. Cengel,et al. Motexafin Lutetium-Photodynamic Therapy of Prostate Cancer: Short- and Long-Term Effects on Prostate-Specific Antigen , 2008, Clinical Cancer Research.
[113] F. Guillemin,et al. Enhancement of meta‐tetrahydroxyphenylchlorin‐sensitized photodynamic treatment on human tumor xenografts using a water‐soluble vitamin E analogue, Trolox , 2000, International journal of cancer.
[114] P. Kuppen,et al. Immunological Aspects of Photodynamic Therapy of Liver Tumors in a Rat Model for Colorectal Cancer¶ , 2003, Photochemistry and photobiology.
[115] D. Salomon,et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. , 2002, Journal of the American Academy of Dermatology.
[116] M. Snell,et al. Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder. , 1976, The Journal of urology.
[117] K. Berg,et al. The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolaevulinic acid-treated cells. , 1996, British Journal of Cancer.
[118] M. Korbelik,et al. Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. , 1999, Cancer research.
[119] J Moan,et al. Lysosomes as photochemical targets , 1994, International journal of cancer.
[120] Mladen Korbelik,et al. Photodynamic therapy-generated vaccine for cancer therapy , 2006, Cancer Immunology, Immunotherapy.
[121] K. Berg,et al. Photochemical internalization (PCI) in cancer therapy: from bench towards bedside medicine. , 2009, Journal of photochemistry and photobiology. B, Biology.
[122] L. Baert,et al. Long-term results of whole bladder wall photodynamic therapy for carcinoma in situ of the bladder. , 1995, Urology.
[123] L. Lilge,et al. Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue , 2000, British Journal of Cancer.
[124] K. Cengel,et al. C225 and PDT combination therapy for ovarian cancer: the play's the thing. , 2005, Journal of the National Cancer Institute.
[125] P. Agostinis,et al. Deficiency in Apoptotic Effectors BAX and BAK Reveals an Autophagic Cell Death Pathway Initiated by Photodamage to the Endoplasmic Reticulum , 2006, Autophagy.
[126] T. Hasan,et al. Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells , 2006, British Journal of Cancer.
[127] Henry Hirschberg,et al. Disruption of the blood–brain barrier following ALA‐mediated photodynamic therapy , 2008, Lasers in surgery and medicine.
[128] E. Rutgers,et al. Intraoperative photodynamic therapy after pleuropneumonectomy in patients with malignant pleural mesothelioma: dose finding and toxicity results. , 2001, Chest.
[129] B. Wilson,et al. The physics, biophysics and technology of photodynamic therapy , 2008, Physics in medicine and biology.
[130] Georg Bartsch,et al. Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study. , 2003, Urology.
[131] S B Malkowicz,et al. Preliminary results of interstitial motexafin lutetium‐mediated PDT for prostate cancer , 2006, Lasers in surgery and medicine.
[132] F. Vargas,et al. Pleural malignancies. , 1996, Current opinion in pulmonary medicine.
[133] Laser treatment of obstructive endobronchial tumors: Factors which determine response , 1987, Lasers in surgery and medicine.
[134] Jean-Jacques Grob,et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. , 2004, Archives of dermatology.
[135] S. Thomson,et al. Effect of photodynamic therapy on recurrent pituitary adenomas: clinical phase I/II trial ‘ an early report , 2000, British journal of neurosurgery.
[136] B. Wilson,et al. A tumor mRNA-triggered photodynamic molecular beacon based on oligonucleotide hairpin control of singlet oxygen production. , 2008, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[137] M. Berns,et al. Mechanism of tumor destruction in photodynamic therapy , 1987 .
[138] C. Elmets,et al. The Immunosuppressive Effects of Phthalocyanine Photodynamic Therapy in Mice Are Mediated by CD4+ and CD8+ T Cells and Can Be Adoptively Transferred to Naive Recipients † , 2008, Photochemistry and photobiology.
[139] Barbara W Henderson,et al. Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils. , 2007, Cancer research.
[140] M. Bentley,et al. Photodynamic Therapy of Skin Cancers: Sensitizers, Clinical Studies and Future Directives , 2000, Pharmaceutical Research.
[141] Yu Bai,et al. Systematic review: photodynamic therapy for unresectable cholangiocarcinoma , 2010, Journal of hepato-biliary-pancreatic sciences.
[142] K. Berg,et al. Multi-Modality Therapeutics with Potent Anti-Tumor Effects: Photochemical Internalization Enhances Delivery of the Fusion Toxin scFvMEL/rGel , 2009, PloS one.
[143] Patrizia Agostinis,et al. ROS-mediated mechanisms of autophagy stimulation and their relevance in cancer therapy , 2010, Autophagy.
[144] Stephen Hahn,et al. The emergence of photodynamic therapy as a major modality in cancer treatment , 1999 .
[145] C. Morton,et al. Randomized comparison of photodynamic therapy with topical 5‐fluorouracil in Bowen's disease , 2003, The British journal of dermatology.
[146] Henry Hirschberg,et al. The effects of ultra low fluence rate single and repetitive photodynamic therapy on glioma spheroids , 2009, Lasers in surgery and medicine.
[147] D. Kessel,et al. PORPHYRIN PHOTOSENSITIZATION OF MULTI‐DRUG RESISTANT CELL TYPES , 1992, Photochemistry and photobiology.
[148] H. Wolfsen. Uses of photodynamic therapy in premalignant and malignant lesions of the gastrointestinal tract beyond the esophagus. , 2005, Journal of clinical gastroenterology.
[149] J. Levy,et al. Immunomodulatory aspects of photodynamic therapy. , 1998, Expert opinion on investigational drugs.
[150] Ann-Marie Wennberg,et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. , 2007, Journal of the American Academy of Dermatology.
[151] M. Biel. Photodynamic therapy and the treatment of head and neck neoplasia , 1998, The Laryngoscope.
[152] Barbara Owczarczak,et al. Photodynamic therapy and anti‐tumor immunity , 2006, Lasers in surgery and medicine.
[153] C Rivano,et al. Fast attempts at the photodynamic treatment of human gliomas. , 1980, Journal of neurosurgical sciences.
[154] Theresa M Busch,et al. Fluence rate as a modulator of PDT mechanisms , 2006, Lasers in surgery and medicine.
[155] D. Kessel. Relocalization of cationic porphyrins during photodynamic therapy , 2002, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[156] Ronald N Germain,et al. Cooperation between CD4+ and CD8+ T cells: when, where, and how. , 2006, Annual review of immunology.
[157] C. Whitehurst,et al. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease , 1996, The British journal of dermatology.
[158] W. Zong,et al. Necrotic death as a cell fate. , 2006, Genes & development.
[159] J. Rees,et al. Treatment for Barrett's oesophagus. , 2002, The Cochrane database of systematic reviews.
[160] Michael R Hamblin,et al. Combination of PDT and a DNA demethylating agent produces anti-tumor immune response in a mouse tumor model , 2009, World Congress of the International Photodynamic Association.
[161] T. Mang,et al. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. , 1985, Cancer research.
[162] J. Krosl,et al. The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. , 1996, Cancer research.
[163] A. Böhle,et al. [BCG versus photodynamic therapy (PDT) for nonmuscle invasive bladder cancer-a multicentre clinical phase III study]. , 2009, Aktuelle Urologie.
[164] Mladen Korbelik,et al. Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. , 2005, Cancer research.
[165] V. Rasheva,et al. Cellular responses to endoplasmic reticulum stress and apoptosis , 2009, Apoptosis.
[166] H. Moseley,et al. Laser and Non-laser Light Sources for Photodynamic Therapy , 2002, Lasers in Medical Science.
[167] A CASTELLANI,et al. Photodynamic effect of haematoporphyrin on blood microcirculation. , 1963, The Journal of pathology and bacteriology.
[168] Li-bo Li,et al. Clinical study of Photofrin photodynamic therapy for the treatment of relapse nasopharyngeal carcinoma. , 2006, Photodiagnosis and photodynamic therapy.
[169] Luigi Corti,et al. Long‐Term survival of patients treated with photodynamic therapy for carcinoma in situ and early non‐small‐cell lung carcinoma , 2007, Lasers in surgery and medicine.
[170] P. Mróz,et al. Antitumor Effects of Photodynamic Therapy Are Potentiated by 2-Methoxyestradiol , 2003, The Journal of Biological Chemistry.
[171] J. Moore,et al. A comparison of the sensitivity to photodynamic treatment of endothelial and tumour cells in different proliferative states. , 1990, International journal of radiation biology.
[172] Malini Olivo,et al. Photodynamic-therapy-activated immune response against distant untreated tumours in recurrent angiosarcoma. , 2007, The Lancet. Oncology.
[173] Paras N Prasad,et al. Organically modified silica nanoparticles co-encapsulating photosensitizing drug and aggregation-enhanced two-photon absorbing fluorescent dye aggregates for two-photon photodynamic therapy. , 2007, Journal of the American Chemical Society.
[174] A. Sytkowski,et al. Erythropoietin inhibits apoptosis induced by photodynamic therapy in ovarian cancer cells , 2008, Molecular Cancer Therapeutics.
[175] I. Tan,et al. mTHPC‐mediated photodynamic therapy for early oral squamous cell carcinoma , 2004, International journal of cancer.
[176] P Muller,et al. Photodynamic therapy of brain tumours--post-operative "field fractionation". , 1991, Journal of photochemistry and photobiology. B, Biology.
[177] S. Bown,et al. Photodynamic therapy for villous adenomas of the colon and rectum. , 1994, Endoscopy.
[178] M. Biel,et al. mTHPC‐mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study of 128 patients , 2004, Head & neck.
[179] Janet Morgan,et al. The Tyrosine Kinase Inhibitor Imatinib Mesylate Enhances the Efficacy of Photodynamic Therapy by Inhibiting ABCG2 , 2007, Clinical Cancer Research.
[180] D. Nowis,et al. Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity , 2006, Oncogene.
[181] N. Oleinick,et al. The photobiology of photodynamic therapy: cellular targets and mechanisms. , 1998, Radiation research.
[182] J. Bergh. Quo vadis with targeted drugs in the 21st century? , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[183] Paul M. Ripley,et al. Photodynamic therapy for cancer of the pancreas , 2002, Gut.
[184] C. Foote. Mechanisms of photosensitized oxidation. There are several different types of photosensitized oxidation which may be important in biological systems. , 1968, Science.
[185] M. Korbelik,et al. Increased tumour dihydroceramide production after Photofrin-PDT alone and improved tumour response after the combination with the ceramide analogue LCL29. Evidence from mouse squamous cell carcinomas , 2009, British Journal of Cancer.
[186] J. Moore,et al. Vascular function and tissue injury in murine skin following hyperthermia and photodynamic therapy, alone and in combination. , 1992, British Journal of Cancer.
[187] P. Steijlen,et al. Fractionated 5‐aminolaevulinic acid–photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial , 2008, The British journal of dermatology.
[188] Andrew H. Kaye,et al. Photodynamic therapy of high grade glioma – long term survival , 2005, Journal of Clinical Neuroscience.
[189] B W Henderson,et al. Role of cytokines in photodynamic therapy-induced local and systemic inflammation , 2003, British Journal of Cancer.
[190] N. Bendsoe,et al. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial , 2001, The British journal of dermatology.
[191] Sung K. Chang,et al. A mechanism-based combination therapy reduces local tumor growth and metastasis in an orthotopic model of prostate cancer. , 2006, Cancer research.
[192] A. Oseroff,et al. Laser and photodynamic therapy in the management of cutaneous malignancies. , 2001, Clinics in dermatology.
[193] T. Okunaka,et al. A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[194] M. Korbelik,et al. Neutrophils as inflammatory and immune effectors in photodynamic therapy-treated mouse SCCVII tumours , 2002, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[195] H Anholt,et al. Photochemical internalization: a novel technology for delivery of macromolecules into cytosol. , 1999, Cancer research.
[196] C. Maake,et al. The application and challenges of clinical PD-PDT in the head and neck region: a short review. , 2010, Journal of photochemistry and photobiology. B, Biology.
[197] K. Moghissi,et al. The place of bronchoscopic photodynamic therapy in advanced unresectable lung cancer: experience of 100 cases. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[198] M. Korbelik,et al. Contribution of myeloid and lymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy. , 1999, Cancer letters.
[199] Yong Zhang,et al. Nanoparticles in photodynamic therapy: an emerging paradigm. , 2008, Advanced drug delivery reviews.
[200] S. Hahn,et al. Patterns of recurrence in patients treated with photodynamic therapy for intraperitoneal carcinomatosis and sarcomatosis. , 2004, International journal of oncology.
[201] S. Hahn,et al. Intraperitoneal photodynamic therapy. , 2007, Cancer treatment and research.
[202] S. Hahn,et al. Photodynamic therapy for mesothelioma , 2001, Current treatment options in oncology.
[203] Timothy Zhu,et al. A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma. , 2003, The Annals of thoracic surgery.
[204] Thomas H Foster,et al. In vivo confocal fluorescence imaging of the intratumor distribution of the photosensitizer mono-L-aspartylchlorin-e6. , 2008, Neoplasia.
[205] A. Sakurada,et al. Results of long-term follow-up of photodynamic therapy for roentgenographically occult bronchogenic squamous cell carcinoma. , 2009, Chest.
[206] T. Dougherty. Photodynamic therapy. , 1993, Photochemistry and photobiology.
[207] P. Speight,et al. Photodynamic therapy using 5‐aminolevulinic acid for premalignant and malignant lesions of the oral cavity , 1996, Cancer.
[208] C J Gomer,et al. Photodynamic therapy-mediated oxidative stress can induce expression of heat shock proteins. , 1996, Cancer research.
[209] H Stepp,et al. Whole bladder photodynamic therapy with 5-aminolevulinic acid using a white light source. , 2003, Urology.
[210] R. Cerfolio,et al. Photodynamic laser therapy for lesions in the airway. , 2010, The Annals of thoracic surgery.
[211] Tayyaba Hasan,et al. Tumor Vascular Permeabilization by Vascular-Targeting Photosensitization: Effects, Mechanism, and Therapeutic Implications , 2006, Clinical Cancer Research.
[212] Barbara W Henderson,et al. Photodynamic therapy: a means to enhanced drug delivery to tumors. , 2003, Cancer research.
[213] J. Piette,et al. Pyropheophorbide-a Methyl Ester-mediated Photosensitization Activates Transcription Factor NF-κB through the Interleukin-1 Receptor-dependent Signaling Pathway* , 1999, The Journal of Biological Chemistry.
[214] D. Kessel. Promotion of PDT Efficacy by a Bcl‐2 Antagonist , 2008, Photochemistry and photobiology.
[215] M. Chopp,et al. Photodynamic therapy with photofrin in combination with Buthionine Sulfoximine (BSO) of human glioma in the nude rat , 2003, Lasers in Medical Science.
[216] A. Lucky,et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. , 2003, Journal of the American Academy of Dermatology.
[217] The role of low-density lipoprotein in the biodistribution of photosensitizing agents. , 1992, Journal of photochemistry and photobiology. B, Biology.
[218] T. Hampton. Targeted Cancer Therapies Lagging , 2006 .
[219] A. Tannapfel,et al. Surgical and Palliative Management and Outcome in 184 Patients With Hilar Cholangiocarcinoma: Palliative Photodynamic Therapy Plus Stenting Is Comparable to R1/R2 Resection , 2006, Annals of surgery.
[220] U. Mansmann,et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. , 2003, Gastroenterology.
[221] M. Korbelik,et al. Photodynamic therapy-generated vaccines: relevance of tumour cell death expression , 2007, British Journal of Cancer.
[222] M. Olivo,et al. Hypericin-mediated photodynamic therapy in combination with Avastin (bevacizumab) improves tumor response by downregulating angiogenic proteins , 2007, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[223] C. Grady,et al. How much is life worth: cetuximab, non-small cell lung cancer, and the $440 billion question. , 2009, Journal of the National Cancer Institute.
[224] S. Ibbotson,et al. A randomized study of minimal curettage followed by topical photodynamic therapy compared with surgical excision for low‐risk nodular basal cell carcinoma , 2007, The British journal of dermatology.
[225] Ascorbic acid suppresses cell death in rat DS-sarcoma cancer cells induced by 5-aminolevulinic acid-based photodynamic therapy. , 2006, Free radical biology & medicine.
[226] A. Jain,et al. LIPOSOMAL DELIVERY OF A PHOTOSENSITIZER, BENZOPORPHYRIN DERIVATIVE MONOACID RING A (BPD), TO TUMOR TISSUE IN A MOUSE TUMOR MODEL , 1993, Photochemistry and photobiology.
[227] Z. Malik,et al. Enhancement of ALA‐PDT Damage by IR‐lnduced Hyperthermia on a Colon Carcinoma Model , 1999, Photochemistry and photobiology.
[228] K. Okita,et al. Experience with photodynamic therapy (endoscopic laser therapy) for the treatment of early gastric cancer. , 2001, Hepato-gastroenterology.
[229] J. Smolle,et al. Photodynamic therapy enhanced by hyperbaric oxygenation in palliation of malignant pleural mesothelioma: clinical experience. , 2004, Photodiagnosis and photodynamic therapy.
[230] K. Okita,et al. The pilot experience of immunotherapy-combined photodynamic therapy for advanced gastric cancer in elderly patients , 2002, International journal of gastrointestinal cancer.
[231] M. Metzdorff,et al. Photodynamic therapy in the palliation of late stage obstructing non-small cell lung cancer. , 1990, Chest.
[232] B. Overholt,et al. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. , 2007, Gastrointestinal endoscopy.
[233] C. Reis e Sousa,et al. Activation of dendritic cells: translating innate into adaptive immunity. , 2004, Current opinion in immunology.
[234] C. Gomer,et al. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors. , 2005, Cancer research.
[235] T. Delaney,et al. Photodynamic therapy of cancer. , 1988, Comprehensive therapy.
[236] Timothy Zhu,et al. Phase II trial of pleural photodynamic therapy and surgery for patients with non-small-cell lung cancer with pleural spread. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[237] C. Morton. Methyl aminolevulinate: actinic keratoses and Bowen's disease. , 2007, Dermatologic clinics.
[238] T. Vanden Berghe,et al. Molecular mechanisms and pathophysiology of necrotic cell death. , 2008, Current molecular medicine.
[239] M. Miyake,et al. siRNA‐mediated Knockdown of the Heme Synthesis and Degradation Pathways: Modulation of Treatment Effect of 5‐Aminolevulinic Acid‐based Photodynamic Therapy in Urothelial Cancer Cell Lines , 2009, Photochemistry and photobiology.
[240] Brian C Wilson,et al. Photodynamic therapy of brain tumors—A work in progress , 2006, Lasers in surgery and medicine.
[241] C J Gomer,et al. Differential cell photosensitivity following porphyrin photodynamic therapy. , 1988, Cancer research.
[242] M. Ruevekamp,et al. Photodynamic therapy in the treatment of multiple primary tumours in the head and neck, located to the oral cavity and oropharynx , 2007, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.
[243] P. Mróz,et al. Effective Photoimmunotherapy of Murine Colon Carcinoma Induced by the Combination of Photodynamic Therapy and Dendritic Cells , 2004, Clinical Cancer Research.
[244] Malini Olivo,et al. Immune response against angiosarcoma following lower fluence rate clinical photodynamic therapy. , 2008, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.
[245] Omar Alqawi,et al. Molecular mechanisms associated with ALA-PDT of brain tumor cells , 2009, World Congress of the International Photodynamic Association.
[246] E. Jeffes,et al. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials. , 2004, Archives of dermatology.
[247] P. Spinelli,et al. Endoscopie treatment of gastrointestinal tumors: Indications and results of laser photocoagulation and photodynamic therapy , 1995 .
[248] A. Evans,et al. Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response. , 2007, The Journal of urology.
[249] J. J. Schuitmaker,et al. Mechanisms for optimising photodynamic therapy: second-generation photosensitisers in combination with mitomycin C. , 1995, British Journal of Cancer.
[250] W. Sluiter,et al. Role of interleukin 1 and granulocyte colony-stimulating factor in photofrin-based photodynamic therapy of rat rhabdomyosarcoma tumors. , 1997, Cancer research.
[251] Michael S Patterson,et al. Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro , 2005, Physics in medicine and biology.
[252] C. Gomer,et al. Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response. , 2007, Cancer research.
[253] G Corbitt,et al. Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. , 2001, Cancer research.
[254] Stephen G Bown,et al. Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study. , 2002, The Journal of urology.
[255] Aleisha Elliott,et al. New Two-Photon Activated Photodynamic Therapy Sensitizers Induce Xenograft Tumor Regressions after Near-IR Laser Treatment through the Body of the Host Mouse , 2008, Clinical Cancer Research.
[256] Johan Moan,et al. Biophysical aspects of photodynamic therapy. , 2006, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.
[257] T. Inokuchi,et al. Inhibitory Effect of Heat Shock Protein 70 on Apoptosis Induced by Photodynamic Therapy In Vitro ¶ , 2004, Photochemistry and photobiology.
[258] M. Eljamel. Photodynamic assisted surgical resection and treatment of malignant brain tumours technique, technology and clinical application. , 2004, Photodiagnosis and photodynamic therapy.
[259] Daniel B. Shin,et al. Photofrin Uptake in the Tumor and Normal Tissues of Patients Receiving Intraperitoneal Photodynamic Therapy , 2006, Clinical Cancer Research.
[260] N. Williams,et al. Adjuvant intraoperative photodynamic therapy in experimental colorectal cancer , 1995, The British journal of surgery.
[261] J. Friedberg. Photodynamic therapy as an innovative treatment for malignant pleural mesothelioma. , 2009, Seminars in thoracic and cardiovascular surgery.
[262] C. Gomer,et al. Avastin enhances photodynamic therapy treatment of Kaposi's sarcoma in a mouse tumor model. , 2006, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.
[263] J Moan,et al. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts. , 2001, Cancer research.
[264] Barbara W. Henderson,et al. Stimulation of the host immune response by photodynamic therapy (PDT) , 2004, SPIE BiOS.
[265] T. Roskams,et al. Antivascular Tumor Eradication by Hypericin-mediated Photodynamic Therapy¶ , 2002, Photochemistry and photobiology.
[266] B. Henderson,et al. Potentiation of Photodynamic Therapy Antitumor Activity in Mice by Nitric Oxide Synthase Inhibition Is Fluence Rate Dependent , 1999, Photochemistry and photobiology.
[267] P. Wolf,et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. , 2006, Archives of dermatology.
[268] S. Gollnick,et al. CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells , 2007, British Journal of Cancer.
[269] M. Adamek,et al. Photodynamic therapy of premalignant lesions and local recurrence of laryngeal and hypopharyngeal cancers , 2001, European Archives of Oto-Rhino-Laryngology.
[270] U. Nseyo,et al. Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder. Bladder Photofrin Study Group. , 1998, The Journal of urology.
[271] A. Curnow,et al. Enhancement of 5-aminolaevulinic acid-induced photodynamic therapy in normal rat colon using hydroxypyridinone iron-chelating agents. , 1998, British Journal of Cancer.
[272] W. Beyer,et al. Systems for light application and dosimetry in photodynamic therapy. , 1996, Journal of photochemistry and photobiology. B, Biology.
[273] J Moan,et al. Intracellular localization of photosensitizers. , 1989, Ciba Foundation symposium.
[274] T. Hasan,et al. Vitamin D enhances ALA-induced protoporphyrin IX production and photodynamic cell death in 3-D organotypic cultures of keratinocytes. , 2007, The Journal of investigative dermatology.
[275] A. Spigelman,et al. Photodynamic therapy for polyps in familial adenomatous polyposis--a pilot study. , 1995, European journal of cancer.
[276] P B Cerrito,et al. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. , 1992, Cancer research.
[277] M. Sam Eljamel,et al. ALA and Photofrin® Fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial , 2008, Lasers in Medical Science.
[278] A. Evans,et al. Vascular‐targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses , 2008, BJU international.
[279] R. Dummer,et al. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen’s disease in transplant recipients , 2004, Transplantation.
[280] Patrizia Agostinis,et al. Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation. , 2010, Biochimica et biophysica acta.
[281] Liang-yan Xue,et al. Photochemical destruction of the Bcl-2 oncoprotein during photodynamic therapy with the phthalocyanine photosensitizer Pc 4 , 2001, Oncogene.
[282] T. Dougherty,et al. Operation and photodynamic therapy for pleural mesothelioma: 6-year follow-up. , 1998, The Annals of thoracic surgery.
[283] J. Usuda,et al. Outcome of Photodynamic Therapy Using NPe6 for Bronchogenic Carcinomas in Central Airways >1.0 cm in Diameter , 2010, Clinical Cancer Research.
[284] F. Hetzel,et al. Hyperoxygenation Enhances the Tumor Cell Killing of Photofrin-mediated Photodynamic Therapy¶ , 2003, Photochemistry and photobiology.
[285] G. Minoli,et al. Photodynamic therapy of nonresectable cholangiocarcinoma , 1999 .
[286] R. Dummer,et al. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8–20 mm), with a 12‐month follow‐up. , 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.
[287] H. Maeda,et al. Polymeric micelles of zinc protoporphyrin for tumor targeted delivery based on EPR effect and singlet oxygen generation , 2007, Journal of drug targeting.
[288] H Kerl,et al. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas? , 1993, Journal of the American Academy of Dermatology.
[289] C. Mosse,et al. How light dosimetry influences the efficacy of photodynamic therapy with 5-aminolaevulinic acid for ablation of high-grade dysplasia in Barrett’s esophagus , 2008, Lasers in Medical Science.
[290] Sari Fien,et al. Photodynamic therapy for non-melanoma skin cancer. , 2007, Journal of the National Comprehensive Cancer Network : JNCCN.
[291] P. Spinelli,et al. Endoscopic treatment of gastrointestinal tumors: indications and results of laser photocoagulation and photodynamic therapy. , 1995, Seminars in surgical oncology.
[292] Timothy Zhu,et al. A Phase II Trial of Intraperitoneal Photodynamic Therapy for Patients with Peritoneal Carcinomatosis and Sarcomatosis , 2006, Clinical Cancer Research.
[293] A. Leunig,et al. Die photodynamische Lasertherapie im Bereich der Hals-, Nasen-, Ohrenheilkunde* , 1993 .
[294] V. Horváth,et al. Mechanisms involved in the cell cycle and apoptosis of HT-29 cells pre-treated with MK-886 prior to photodynamic therapy with hypericin. , 2008, Journal of photochemistry and photobiology. B, Biology.